missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VEGF 121 (aa 207-327) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 4644-VS-010/CF
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 1.00-8.00 ng/mL.Especificaciones
| Lyophilized from a 0.2μm filtered solution in HCl. | |
| 14 kDa | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 7422 | |
| VEGF 121, aa 207-327 | |
| E. coli-derived human VEGF protein Ala207-Arg327,with an N-terminal Met & Pro208-Arg327 | |
| Disulfide-linked homodimer | |
| Recombinant |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido